Circulating Natural Killer Cells in Patients With Type 2 Diabetes and Peripheral Neuropathy Are Altered in Their Frequency and Exhibit Impaired Functions and Angiogenic Activities
The FASEB Journal · 31.10.2026 · 40 (20)
DOI: 10.1096/fj.202600263r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 17.10.2026. Verfasst von Maria Teresa Palano und 22 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Innate Immunity, Unit of Molecular Pathology, Biochemistry, and Immunology, IRCCS MultiMedica, Milan, Italy. Hauptthemen laut MEDLINE: Killer Cells, Natural, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Angiogenesis. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell'Università e della Ricerca (MIUR), Italian Ministry of Health, The Diabetic Association of Treviso Onlus ODV.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Patients with type 2 diabetes mellitus (T2DM) and critical limb‐threatening ischemia (CLTI), a severe vascular complication associated with amputation and high mortality, exhibit chronic inflammation and endothelial dysfunction. We previously reported an increased frequency of natural killer (NK) cells in advanced CLTI; however, whether NK cell alterations are already present in patients with peripheral neuropathy, which often precedes diabetic foot lesions with or without distal macroangiopathy, remains unclear. We conducted an observational pilot study to assess circulating NK cell frequency by flow cytometry and inflammatory plasma cytokines profiling by ELISA in 177 subjects stratified into five groups: healthy controls (HC, n = 25); T2DM without neurovascular complications (D, n = 26); non‐macrovascular neuropathic T2DM without foot lesions (N, n = 40); non‐macrovascular neuropathic T2DM with lower‐limb ulcers/lesions/osteomyelitis (N1, n = 42); and macrovascular revascularized neuropathic T2DM with ulcers/lesions/osteomyelitis (NV, n = 44). NK cell subset frequencies were evaluated in an independent cohort of patients with non‐macrovascular neuropathic T2DM ( n = 22) and healthy controls ( n = 23). NKs were further characterized for degranulation capacity, secretome composition, and pro‐angiogenic activity in vitro and in vivo ( Hirudo verbana ). NK cell frequency was significantly increased in patients with non‐macrovascular neuropathic T2DM compared with controls and was accompanied by elevated plasma levels of soluble mediators associated with NK cell activation and function, including TNF‐α, IL‐12p70, MCP‐1, and IL‐4. NKs from these patients exhibited impaired degranulation and reduced angiogenic capacity in vitro and in vivo. Their secretome is characterized by decreased release of pro‐angiogenic factors and increased secretion of mediators involved in monocyte/macrophage recruitment, resulting in enhanced macrophage recruitment in vivo. If confirmed in larger cohorts, higher frequency and functional impairment of circulating NKs may act as novel therapeutic targets and prognostic biomarkers in peripheral vascular complications of T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Innate Immunity, Unit of Molecular Pathology, Biochemistry, and Immunology, IRCCS MultiMedica, Milan, Italy.
- Cardiovascular Pathophysiology and Regenerative Medicine Laboratory, IRCCS MultiMedica, Milan, Italy.
- Endocrine, Metabolism, and Nutrition Disease Unit, Santa Maria of Ca' Foncello Hospital, Treviso, Italy.
- Value-Based Health Care Unit, IRCCS MultiMedica, Milan, Italy.
- Department of Bioscience, University of Milan, Milan, Italy.
- Laboratory of Translational Immunology, Centro di Ricerca Per L'invecchiamento di Successo (CRIS), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
ORCID-Profile: Maria Teresa Palano, Federica Riccio, Luisa Sambado, Elena Tagliabue, Milena Bertolotti, Marzia Campanile, Martina Mutoli, Fiorenza Lotti, Andrea Rampin, Antonio Antico, Matteo Fassan, Piero Maria Stefani, Paola Ostano, Giovanna Chiorino, Nicolò Baranzini, Laura Pulze, Annalisa Grimaldi, Antonino Bruno, Maria Sambataro, Gaia Spinetti
Förderung
- Ministero dell'Università e della Ricerca (MIUR)
- Italian Ministry of Health
- The Diabetic Association of Treviso Onlus ODV
- Italian Ministry of Health Ricerca Corrente to the IRCCS MultiMedica
- Ministero dell'Istruzione e del Merito
- Ministero della Salute
Zitieren
APA
Palano, M. T., Riccio, F., Sambado, L., Tagliabue, E., Bertolotti, M., Campanile, M., Mutoli, M., Lotti, F., Rampin, A., Rubuano, C., Maspero, G., Antico, A., Pitzalis, F., Fassan, M., Stefani, P. M., Ostano, P., Chiorino, G., Baranzini, N., Pulze, L., …, & Spinetti, G. (2026). Circulating Natural Killer Cells in Patients With Type 2 Diabetes and Peripheral Neuropathy Are Altered in Their Frequency and Exhibit Impaired Functions and Angiogenic Activities. The FASEB Journal, 40(20). https://doi.org/10.1096/fj.202600263r
Vancouver
Palano MT, Riccio F, Sambado L, Tagliabue E, Bertolotti M, Campanile M, et al. Circulating Natural Killer Cells in Patients With Type 2 Diabetes and Peripheral Neuropathy Are Altered in Their Frequency and Exhibit Impaired Functions and Angiogenic Activities. The FASEB Journal. 2026;40(20). doi:10.1096/fj.202600263r
BibTeX
@article{Palano2026,
author = {Palano, Maria Teresa and Riccio, Federica and Sambado, Luisa and Tagliabue, Elena and Bertolotti, Milena and Campanile, Marzia and Mutoli, Martina and Lotti, Fiorenza and Rampin, Andrea and Rubuano, Cristian and Maspero, Giorgia and Antico, Antonio and Pitzalis, Francesca and Fassan, Matteo and Stefani, Piero Maria and Ostano, Paola and Chiorino, Giovanna and Baranzini, Nicolò and Pulze, Laura and Grimaldi, Annalisa and Bruno, Antonino and Sambataro, Maria and Spinetti, Gaia},
title = {Circulating Natural Killer Cells in Patients With Type 2 Diabetes and Peripheral Neuropathy Are Altered in Their Frequency and Exhibit Impaired Functions and Angiogenic Activities},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {20},
doi = {10.1096/fj.202600263r}
}
EUVIMED